FDA Approves Bone Building Therapy

ADC Logo with The Austin Diagnostic Clinic

For Immediate Release:
May 10, 2017

Contact: Rocky Epstein
ADC Marketing and Communications Director
512-901-4448 or repstein@adclinic.com

Newly FDA Approved Bone Building Therapy Sparks Hope for Patients with Osteoporosis

Osteoporosis specialist Michele McDermott, MD explains why this therapy is a gamechanger

AUSTIN, TX – This May the FDA approved a new bone building agent for the treatment of postmenopausal women at a high risk for fracture.   Tymlos™ (abaloparatide) from Radius Health reduces the risk of vertebral and non-vertebral fractures and increases the bone mineral density (BMD) in patients.  This new treatment is a significant for postmenopausal women who are unable to take other available osteoporosis therapies due to intolerance. Tymlos™ is administered daily subcutaneous injection.

Michele McDermott, MD, Osteoporosis specialist and director of Bone Densitometry at The Austin Diagnostic Clinic explains why this new therapy is so important.

“Tymlos stands apart from the older and most commonly prescribed medications because it is able to repair the bone structure by forming new bone. Osteoporosis is a disorder that affects postmenopausal women due to loss of estrogen. There is an imbalance of bone remodeling that causes bone to be removed at a faster rate that it is replaced. This results in loss of bone density and breakdown of the bone structure. Tymlos reverses this process by stimulating formation of new bone.”

How many people may be affected by osteoporosis?

Osteoporosis is a silent disease, often displaying no signs or symptoms until a fracture occurs; leaving the majority of patients undiagnosed and untreated, representing a high unmet medical need. Osteoporotic fractures create a significant healthcare burden. An estimated two million osteoporotic fractures occur annually in the United States, and this number is projected to grow to three million by 2025.

The National Osteoporosis Foundation (NOF) has estimated that eight million women already have osteoporosis, and another approximately 44 million may have low bone mass placing them at increased risk for osteoporosis.

The annual incidence of osteoporotic fractures is higher than that of stroke, heart attack and breast cancer combined; osteoporotic fractures also account for more hospitalizations and associated costs than cardiovascular disease and breast cancer. Of concern for many providers is that the number of screenings being performed is decreasing along with the number of prescriptions written, leaving many individuals vulnerable to life-altering fractures.

“It is our hope that we will be able to reach more women and help prevent and reduce the risk of fracture with this new therapy.” Says Dr. McDermott.


The Austin Diagnostic Clinic is an independent group of 130 doctors and providers practicing in 21 medical specialties at 9 locations throughout Central Texas since 1952.   Our vision is to be the premier multispecialty clinic providing compassionate care and excellent service. ADC doctors have been caring for Central Texans and their families since 1952.